GENERIC NAME OF THE MEDICINAL PRODUCT:

A) Levosalbutamol Inhalation Solution 0.31mg
B) Levosalbutamol Inhalation Solution 0.63mg
c) Levosalbutamol Inhalation Solution 1.25mg

QUALITATIVE AND QUANTITATIVE COMPOSITION:

A) Levosalbutamol Inhalation Solution 0.31mg
Each Composition:
Each 2.5ml contains:
Levosalbutamol Sulphate BP
Eq. to Levosalbutamol…………………….0.31mg
In an isotonic solution………………………….Q.S.
B) Levosalbutamol Inhalation Solution 0.63mg
Each Composition:
Each 2.5ml contains:
Levosalbutamol Sulphate BP
Eq. to Levosalbutamol…………………….0.63mg
In an isotonic solution………………………….Q.S.
c) Levosalbutamol Inhalation Solution 1.25mg
Each Composition:
Each 2.5ml contains:
Levosalbutamol Sulphate BP
Eq. to Levosalbutamol…………………….1.25mg
In an isotonic solution………………………….Q.S.

THERAPEUTIC INDICATIONS:

Levosalbutamol makes breathing easier for patients with chronic obstructive pulmonary disease (COPD).

CAUTION & WARNING:

CAUTION: Even invisible damage to respule caused during storage or transit may result in contamination. Do not use, and return for replacement if the solution is discoloured, leak found on squeezing or contains visible black particles.
Read enclosed leaflet before use.
KEEP MEDICINE OUT OF REACH OF CHILDREN.
WARNING: To be sold by retail on the prescription of a Registered Medical Practitioner only.

STORAGE & DOSAGE:

Storage: Store the respules in foil pouch at all times.
Once the foil pouch is opened the respules should be used within one month.
Store below 25°C.
Protect from light.
Do not freeze.
Dosage: As per directed by physician.

Levosalbutamol Inhalation Solution 0.31mg Technical Specification:

Product Name:Levosalbutamol Inhalation Solution
Brand Name:Generic
Strength:0.31mg, 0.63mg, 1.25mg
Dosage Form:Nebuliser / Respules for inhalation Only
Route of Administration:Via Inhalation Route Only
Packing:2.5ml Respules
Pack Insert/Leaflet:PIL (Patient Information Leaflet), SmPC (Summary Product Characteristics)
Regulatory Documents:COA, MOA, COPP, FSC, Stability Studies, GMP, CTD Dossier
Therapeutic use:β Agonist, Bronchodilators
Indication: Levosalbutamol makes breathing easier for patients with chronic obstructive pulmonary disease (COPD).
Storage:Store below 25°C. Protect from light. Do not freeze.

GENERIC NAME OF THE MEDICINAL PRODUCT:

  • Levosalbutamol Inhalation Solution 0.31mg
  • Levosalbutamol Inhalation Solution 63mg
  • Levosalbutamol Inhalation Solution 25mg

QUALITATIVE AND QUANTITATIVE COMPOSITION:

  • Levosalbutamol Inhalation Solution 0.31mg
    Each Composition: <br>
    Each 2.5ml contains: <br>
    Levosalbutamol Sulphate BP<br>
    Eq. to Levosalbutamol…………………….0.31mg<br>
    In an isotonic solution………………………….Q.S. <br></b>
  • Levosalbutamol Inhalation Solution 0.63mg <br>
    Each Composition: <br>
    Each 2.5ml contains: <br>
    Levosalbutamol Sulphate BP<br>
    Eq. to Levosalbutamol…………………….0.63mg<br>
    In an isotonic solution………………………….Q.S.
  • Levosalbutamol Inhalation Solution 1.25mg <br>
    Each Composition: <br>
    Each 2.5ml contains: <br>
    Levosalbutamol Sulphate BP<br>
    Eq. to Levosalbutamol…………………….1.25mg<br>
    In an isotonic solution………………………….Q.S. <br>

THERAPEUTIC INDICATIONS:

Levosalbutamol makes breathing easier for patients with chronic obstructive pulmonary disease (COPD).

CAUTION & WARNING:

CAUTION:Even invisible damage to respule caused during storage or transit may result in contamination.
Do not use, and return for replacement if the solution is discoloured, leak found on squeezing or contains visible black particles.
Read enclosed leaflet before use.
Keep medicine out of reach of children.
Warning: To be sold by retail on the prescription of a Registered Medical Practitioner only.

STORAGE & DOSAGE:

Storage: Store the respules in foil pouch at all times.
Once the foil pouch is opened the respules should be used within one month.
Store below 25°C.
Protect from light.
Do not freeze.
Dosage: As per directed by physician.